Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}-amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists.

被引:9
作者
Dack, KN [1 ]
Dickinson, RP
Long, CJ
Steele, J
机构
[1] Pfizer Ltd, Cent Res, Dept Discovery Chem, Sandwich CT13 9NJ, Kent, England
[2] Pfizer Ltd, Cent Res, Dept Discovery Biol, Sandwich CT13 9NJ, Kent, England
关键词
D O I
10.1016/S0960-894X(98)00242-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design of a series of thromboxane receptor antagonists based on 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid (1) is described. Addition of an arylmethyl group at the 5-position of 1 gave exceptionally potent agents in vitro and in vivo, with 13a (UK-147,535) giving complete blockade of the TxA(2) receptor for greater than 12 hours in dogs, following all oral dose of 0.1 mg/kg. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2061 / 2066
页数:6
相关论文
共 13 条
[1]  
Bhagwat Shripad S., 1994, Drugs of the Future, V19, P765
[2]  
COLLINGTON EW, 1990, ANNU REP MED CHEM, V25, P99
[3]  
COZZI P, 1991, CURR OPINION THERAPE, P1343
[4]   SELECTIVE THROMBOXANE SYNTHETASE INHIBITORS .1. 1-[(ARYLOXY)ALKYL]-1H-IMIDAZOLES [J].
CROSS, PE ;
DICKINSON, RP ;
PARRY, MJ ;
RANDALL, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (10) :1427-1432
[5]  
CROSS PE, 1987, ANNU REP MED CHEM, V22, P95
[6]   Thromboxane modulating agents .3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists [J].
Dickinson, RP ;
Dack, KN ;
Long, CJ ;
Stelle, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3442-3452
[7]   Thromboxane modulating agents .2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel [J].
Dickinson, RP ;
Dack, KN ;
Steele, J ;
Tute, MS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (14) :1691-1696
[8]   Thromboxane modulating agents .1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor thromboxane receptor antagonists [J].
Dickinson, RP ;
Dack, KN ;
Steele, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (24) :3017-3022
[9]   THE BIOCHEMICAL PHARMACOLOGY OF THROMBOXANE SYNTHASE INHIBITION IN MAN [J].
FITZGERALD, GA ;
REILLY, IAG ;
PEDERSEN, AK .
CIRCULATION, 1985, 72 (06) :1194-1201
[10]   THROMBOXANE A2 RECEPTOR ANTAGONISTS [J].
HALL, SE .
MEDICINAL RESEARCH REVIEWS, 1991, 11 (05) :503-579